Open Access
Identification of antibody-drug conjugate payloads that are substrates of ATP-binding cassette drug efflux transporters
12 Jan 2026
Cancer Drug Resistance
Open Access
About the journal
A dedicated home for research on cancer drug resistance.
Cancer Drug Resistance is an international Open Access journal dedicated to understanding and overcoming treatment resistance in cancer. We publish basic, translational, and clinical research on the mechanisms, evolution, biomarkers, and therapeutic strategies underlying or reversing resistance.
Key areas include: targeted therapies · immunotherapy · antibody–drug conjugates · radioligand therapy · cellular therapies · liquid biopsy · cancer evolution · emerging resistance mechanisms and therapeutic approaches.
Novel anti-tumor strategies: targeting the crosstalk between cancer stem cells and cancer-associated fibroblasts to resist drug resistance
20 Jan 2026
Bracing for the storm: emerging resistance mechanisms to KRAS inhibitors in pancreatic cancer and strategies to overcome them
31 Aug 2026
The epigenetic mechanisms involved in the treatment resistance of glioblastoma
12 Mar 2025
Acquired resistance to molecularly targeted therapies for cancer
4 Jun 2025
Resistance to third-generation EGFR TKIs - what can be expected from the fourth-generation?
3 Sep 2026
Cheng-Shuo Huang
, ...Jar-Yi Ho
, ...Jar-Yi Ho
21 Oct 2026
Wolfram C. M. Dempke, ...Martin Reck
3 Sep 2026, ...Martin Reck Marco Pagano Mariano, ...Elisa Giovannetti
31 Aug 2026 Melis Poyraz, ...Cyril Corbet
28 Aug 2026, ...Cyril Corbet Most Cited Papers in Last Two Years
Darin Poei, ... Robert Hsu
22 May 2024
Jindong Xie, ... Xiaoming Xie
, ... Xiaoming Xie
6 Jan 2025
Topics Collection
Topic: Overcoming Drug Resistance in Solid Tumors: Nanotechnology, Precision Medicine, and Multimodal Therapies Submission deadline: 26 Jun 2026
Topic: Advancements in Precision Medicine for Overcoming Cancer Drug Resistance Submission deadline: 30 Dec 2025
Topic: Genomic and Genetic Alterations Associated with Cancer Drug Resistance Submission deadline: 20 Nov 2025
.jpg)
1 / 9
Related Journals
Extracellular Vesicles and Circulating Nucleic Acids
Editor-in-Chief: Yoke Peng Loh
Journal of Cancer Metastasis and Treatment
Editor-in-Chief: Ciro Isidoro
1 / 1
2548
Authors
3297
Reviewers
2018
Published Since
Cancer Drug Resistance
Editor-in-Chief: Godefridus J. Peters
Indexing: ESCI, PMC, Scopus, CAS, CNKI, etc.
Median time to first editorial decision: 9 days
7.6 Impact Factor
10.3 CiteScore
Q1 JCR Quartile
See More
7.6 Impact Factor
10.3 CiteScore
PLA2G2A across tumor compartments and its relevance to drug resistance
Randomized multicentre Phase 2 clinical trial of non-viral gene therapy for pancreatic cancer: clinical and molecular findings
Extracellular vesicles as integrative hubs of drug resistance in bladder cancer
Cheng-Shuo Huang, ...Jar-Yi Ho
21 Oct 2026
, ...Jar-Yi Ho
21 Oct 2026
Tumor microenvironment-driven therapeutic resistance in pancreatic ductal adenocarcinoma
Ferroptosis-related signaling pathways in cancer drug resistance
5 Jan 2025
NFE2L2 and ferroptosis resistance in cancer therapy
24 Oct 2024
ALK inhibitors in cancer: mechanisms of resistance and therapeutic management st...
22 May 2024
Cancer-associated fibroblast-derived extracellular vesicles: regulators and ther...
6 Jan 2025
Topic: Targeting the Cancer Cell Surfaceome in Radioligand Therapy Resistance: Mechanisms of Resistance and Therapeutic Adaptation
Submission Deadline: 15 Aug 2027 Published articles: 0
Topic: Liquid Biopsy in Lung Cancer: Monitoring Response and Resistance
Submission Deadline: 30 Jun 2027 Published articles: 0
Advancements in Precision Medicine for Overcoming Cancer Drug Resistance
Prof. Juyoung Yoon; Prof. Jianliang Shen
Submission deadline: 30 Dec 2025
Role of Non-Coding RNA in Cancer Drug Resistance
Prof. Hailin Tang
Submission deadline: 20 May 2024
Resistance to Cancer Immunotherapy: Mechanisms, Advances, Challenges and Opportunities
Dr. Michael Lahn; Dr. Jordi Rodon; Prof. Hendrik Tobias Arkenau
Submission deadline: 30 Apr 2023
Topic: Overcoming Drug Resistance in Solid Tumors: Nanotechnology, Precision Medicine, and Multimodal Therapies Submission deadline: 26 Jun 2026
Topic: Advancements in Precision Medicine for Overcoming Cancer Drug Resistance Submission deadline: 30 Dec 2025
Topic: Genomic and Genetic Alterations Associated with Cancer Drug Resistance Submission deadline: 20 Nov 2025
Volume 9 (in progress) Volume 8 Volume 7 Volume 6, Issue 4 Volume 6, Issue 3 Volume 6, Issue 2 Volume 6, Issue 1 Volume 5, Issue 4 Volume 5, Issue 3 Volume 5, Issue 2 Volume 5, Issue 1 Volume 4, Issue 4 Volume 4, Issue 3 Volume 4, Issue 2 Volume 4, Issue 1 Volume 3, Issue 4 Volume 3, Issue 3 Volume 3, Issue 2 Volume 3, Issue 1 Volume 2, Issue 4 Volume 2, Issue 3 Volume 2, Issue 2 Volume 2, Issue 1 Volume 1, Issue 4 Volume 1, Issue 3 Volume 1, Issue 2 Volume 1, Issue 1
Volumes ebook
Breaking Resistance, Shaping the Future | Research Voices (Episode 8) - Prof. Martine Piccart, Université libre de Bruxelles，Institut Jules Bordet
Call for Applications: Cancer Drug Resistance Early-Career Editorial Board - Advancing the future of cancer drug resistance researchBreaking Resistance, Shaping the Future: Cancer Drug Resistance Launches Its 8th Anniversary Scientific Series with a Special Message from Editor-in-Chief Prof. Godefridus J. Peters
.jpeg)
2548
Authors
3297
Reviewers
2018
Published Since
